Ashburn Theodore Insider Trades

Insider Trading History

Track insider trading activity for Ashburn Theodore. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Oncorus
Oncorus ONCR
President And CEO
Holding Value $26.6k 211,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422k 211,000 shares
$2.00
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $32.2k 255,768 shares
Last Trade
Nov 19, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$189k 32,500 shares
$5.83
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $12.5k 99,352 shares
Last Trade
Nov 19, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$189k 32,500 shares
$5.83
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $36.3k 288,268 shares
Last Trade
Oct 22, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$443k 43,707 shares
$10.13
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $8.42k 66,852 shares
Last Trade
Oct 22, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$443k 43,707 shares
$10.13
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $2.92k 23,145 shares
Last Trade
Apr 07, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$64.7k 4,699 shares
$13.76
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $42.4k 336,546 shares
Last Trade
Apr 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$64.7k 4,699 shares
$13.76
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $25.1k 199,000 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.15M 199,000 shares
$15.85
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $41.8k 331,975 shares
Last Trade
Dec 31, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$61.4k 1,900 shares
$32.33
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $2.32k 18,446 shares
Last Trade
Dec 31, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$61.4k 1,900 shares
$32.33
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $2.08k 16,546 shares
Last Trade
Oct 01, 2020 Sale
No data
No data
$0.13
Oncorus
Oncorus ONCR
President And CEO
Holding Value $16k 126,624 shares
Last Trade
Oct 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.13
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
See Remarks
Holding Value $2.87M 75,000 shares
Last Trade
Jan 08, 2016 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$682k 75,000 shares
$9.09
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
See Remarks
Holding Value $127k 3,333 shares
Last Trade
Jan 09, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.7k 3,333 shares
$18.50
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
See Remarks
Holding Value $4.4M 115,000 shares
Last Trade
Dec 15, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 115,000 shares
$13.08
$38.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up